Uncategorized

Sacramento, Calif.-based UC Davis Health has permanently named David Cooke, MD, as physician-in-chief for the UC Davis Comprehensive Cancer Center. 

The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and…

The global cancer burden of adolescents and young adults is projected to increase by approximately 12% by 2050, according to a Nov. 15 study published in The Lancet Oncology. 

Penn Medicine Lancaster (Pa.) General Health has named Efrat Dotan, MD, as executive medical director of the Ann B. Barshinger Cancer Institute.

Compared to primary care physicians, dermatologists have 13.3-fold higher accuracy when diagnosing melanoma using dermoscopic images, according to a study published Nov. 13 in JAMA Dermatology. 

Somerville, Mass.-based Mass General Brigham has appointed Patrick Ellinor, MD, PhD, as the inaugural executive director of the system's Heart and Vascular Institute.

Surgeons at Cincinnati-based The Christ Hospital performed a successful human implantation of the BiVACOR Total Artificial Heart, marking the fourth hospital in the U.S. to complete the procedure as part of the FDA's early feasibility study.

The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems.

Bryan Bell, MD, DDS, has accepted the roles of executive medical director of Providence Cancer Institute and director of its research arm, the Earle A. Chiles Research Institute, both based in Portland, Ore., according to a news release shared with…

The University of Chicago Medicine Comprehensive Cancer Center has partnered with the Energy Department to harness the technology of the department's Argonne National Laboratory toward the development of treatments for drug-resistant cancers.